Sign in
4

Changes in Ownership

Neumora Therapeutics, Inc. Filed Acc 0000950170-25-022326

Options or other derivatives

  • Director acquired 141,959 shares (grant or award)
  • Director returned 141,959 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Fust Matthew K · Director

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2025-02-13 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −85,586 0 D
2025-02-13 Returned to the company : show line 2 in the form Stock Option (Right to Buy) −27,802 0 D
2025-02-13 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −28,571 0 D
2025-02-13 Grant or award : show line 4 in the form Stock Option (Right to Buy) +85,586 85,586 D
2025-02-13 Grant or award : show line 5 in the form Stock Option (Right to Buy) +27,802 27,802 D
2025-02-13 Grant or award : show line 6 in the form Stock Option (Right to Buy) +28,571 28,571 D
Loading xslF345X05/ownership.xml…